ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.
Our expert team establishes and communicates a product’s unique clinical and economic outcomes to achieve success in today’s dynamic and patient-centric healthcare environment.
ICO specialty practices include:
- Peri-approval & Observational Research
- Global Pricing & Market Access
- Health Economics & Epidemiology
- Clinical Outcomes Assessment
- Healthcare Communications
- Language Services
ICO ultimately helps clients make the best decisions based on academically rigorous and commercially relevant expertise and services early in development so that they can introduce the highest value product into the market place in the shortest time.